Combination pharmacotherapy in unipolar depression
نویسندگان
چکیده
منابع مشابه
Dextroamphetamine and Pramipexole Combination for Treatment-Resistant Unipolar Depression.
CASE REPORT The patient was a 40-year-old man with TRD stage III1 who had good response to four sessions of electroconvulsive therapy in the past. The following medications had not worked for him: fluoxetine, sertraline, escitalopram 30 mg, citalopram, venlafaxine, mirtazapine 45 mg, bupropion 300 mg, buspirone 60 mg, and methylphenidate 10 mg (the patient noted that taking methylphenidate 10 m...
متن کاملUnipolar Depression in Paroxysmal Schizophrenia
Based on the current study, the clinical characteristics of unipolar depression in the clinical picture of schizophrenia with the paroxysmal type of disease course are presented. Given the concomitant depression with phobic symptoms, the following clinical variants are marked: depression with generalized social phobia and/or anthropophobia and depression with generalized pathological body sensa...
متن کاملBipolar and unipolar depression.
Since Kraepelin grouped affective disorders under the title of 'manic-depressive insanity', there has been controversy over whether the bipolar and unipolar entities within this are distinct affective disorders or whether they are merely two ends of an affective continuum. In order to bring some clarity and goal-posts to this argument, we define the criteria that must be fulfilled by diseases i...
متن کاملCombination Drugs: Innovation in Pharmacotherapy
A lthough most pharmaceutical innovation is incremental, small improvements in therapy often add up to substantial progress over time.1 Incremental innovation in drug therapy can take various forms, including new agents, new indications for existing drugs, and new dosage forms with improved pharmacologic profiles.1 Combination therapy with two or more agents having complementary mechanisms of a...
متن کاملCombination pharmacotherapy in Alzheimer's disease
Alzheimer's disease is a progressive, debilitating form of dementia affecting more than 18 million people worldwide. Without a cure, many patients and their families must turn to long-term care institutions during the later stages of the disease. Our current treatments only delay progression and help control behavioral symptoms. In recent years, research within this field has expanded to includ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Expert Review of Neurotherapeutics
سال: 2006
ISSN: 1473-7175,1744-8360
DOI: 10.1586/14737175.6.7.1049